A clear account of the capability threshold at which a research-AI tool stops having to prove itself by shipping its own product — the same trap facing anyone selling models into a domain with slow, expensive feedback.

• article🔬Causal Models Need Causal Data - Xaira’s X-Cell model for Drug Discovery (Bo Wang & Ci Chu, Chief Discovery Officer & Chief AI Scientist)

• videoAnthropic and Chai Discovery on AI-Accelerated Drug DevelopmentStanford Online
• videoTrading Desks to Clinical Trials: Parallels in Applied Vertical AI — Ayush Bhardwaj, Allos AIAI Engineer
• videoWhy We Killed Our Multi-Agent Pipeline — Subbiah Sethuraman and Abhilash Asokan, ZS AssociatesAI Engineer

Checking sign-in…

Loading comments…